Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGattaca Regulatory News (GATC)

Share Price Information for Gattaca (GATC)

Share Price is delayed by 15 minutes
Get Live Data
137.50    -5.00 (-3.51%)
Bid:
135.00
Ask:
140.00
Spread: 5.00 (3.704%)
Market Cap: £42.47m
GATC Live PriceLast checked at - London Stock Exchange

Intraday Gattaca Share Chart

Form 8.3 - Matchtech Group Plc

29 Jan 2015 10:57

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Identity of the person whose positions/dealings are being disclosed: HARGREAVE HALE LIMITED (for Discretionary Clients)
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

MATCHTECH GROUP PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

28 JANUARY 2015

(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?

YES: NETWORKERS INTERNATIONAL PLC

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: ORDINARY 1p

Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled: 10,640 0.0426
(2) Derivatives (other than options):
(3) Options and agreements to purchase/sell:

TOTAL:

10,640 0.0426

All interests and all short positions should be disclosed.

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other executive options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

(a) Purchases and sales

Class of relevant security Purchase/sale Number of securities Price per unit
NONE

(b) Derivatives transactions (other than options)

Class of relevant security Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities Price per unit
NONE

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit
NONE

(ii) Exercising

Class of relevant security Product description

e.g. call option

Number of securities Exercise price per unit
NONE

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)
NONE

The currency of all prices and other monetary amounts should be stated.

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state “none”

NONE

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

NONE

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 29 JANUARY 2015
Contact name: DAVID CLUEIT
Telephone number: 01253 754739

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Copyright Business Wire 2015

Date   Source Headline
9th Dec 20169:25 amRNSBlock Admission
8th Dec 201610:24 amRNSDirector/PDMR Shareholding
8th Dec 20167:00 amRNSResult of AGM
5th Dec 201612:08 pmRNSBLOCK LISTING SIX MONTHLY RETURN
25th Nov 20168:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
16th Nov 20162:08 pmRNSNotice of AGM
3rd Nov 20167:00 amRNSPreliminary Results
26th Sep 20167:00 amRNSSite Visit
12th Sep 20167:00 amRNSChange of name and website
19th Aug 20167:00 amRNSProposal for Change of Name - Notice of EGM
11th Aug 20163:59 pmRNSDirector/PDMR Shareholding
4th Aug 20167:00 amRNSTrading Update for 12 months ended 31 July 2016
22nd Jul 20164:40 pmRNSSecond Price Monitoring Extn
22nd Jul 20164:35 pmRNSPrice Monitoring Extension
21st Jul 20162:05 pmRNSDirector / PDMR Shareholding
18th Jul 20167:00 amRNSMatchtech Group plc to become Gattaca plc
7th Jul 20167:00 amRNSDirector/PDMR Shareholding
6th Jun 20162:59 pmRNSBlock Listing Six Monthly Return
14th Apr 20167:00 amRNSInterim Results to 31 January 2016
18th Feb 20164:40 pmRNSSecond Price Monitoring Extn
18th Feb 20164:35 pmRNSPrice Monitoring Extension
15th Feb 20164:43 pmRNSDirector/PDMR Shareholding
12th Feb 20167:00 amRNSDirector/PDMR Shareholding
28th Jan 20167:00 amRNSTrading Update
27th Jan 20161:00 pmRNSDirector/PDMR Shareholding
19th Jan 20161:15 pmRNSCorrection - Director / PDMR Shareholding
18th Jan 20167:00 amRNSDirector/PDMR Shareholding
7th Dec 20153:37 pmRNSDirector/PDMR Shareholding
2nd Dec 20152:24 pmRNSResult of AGM
2nd Dec 20157:00 amRNSAGM Statement
24th Nov 20153:34 pmRNSNotice of AGM
29th Oct 20157:02 amRNSAppointment of Patrick Shanley as Chairman
29th Oct 20157:00 amRNSFinal Results
14th Oct 20157:00 amRNSNotice of Results
25th Aug 20152:40 pmRNSHolding(s) in Company
6th Aug 20154:12 pmRNSDirector/PDMR Shareholding
6th Aug 20157:00 amRNSTrading Update for 12 months ended 31 July 2015
31st Jul 20157:00 amRNSResignation of Non-Executive Director
21st Jul 201510:08 amRNSDirector/PDMR Shareholding
6th Jul 20157:00 amRNSNotification of awards under Value Creation Plan
2nd Jun 20154:52 pmRNSBlock Listing Six Monthly Return
21st Apr 201512:05 pmRNSHolding(s) in Company
21st Apr 201512:05 pmRNSDirector/PDMR Shareholding
17th Apr 20155:17 pmRNSHolding(s) in Company
17th Apr 201510:26 amRNSDirector/PDMR Shareholding
10th Apr 20159:00 amRNSBlocklisting Application
9th Apr 20157:00 amRNSNew Business Update
9th Apr 20157:00 amRNSHalf Year Financial Report
8th Apr 20151:42 pmRNSForm 8.3 - MATCHTECH GROUP
2nd Apr 20157:05 amRNSAppointment of Non-Executive Director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.